Latent Membrane Protein-1 Protein Induction toward Vascular Endothelial Growth Factor Expression in the Development of Nasopharyngeal Carcinoma
BACKGROUND: Nasopharyngeal carcinoma (NPC) is associated with Epstein–Barr virus infection as the main factor. Latent membrane protein (LMP)-1 protein and vascular endothelial growth factor (VEGF) have been suggested as the prognostic biomarker for NPC.
AIM: This study is conducted to analyze the overexpression of LMP-1 protein and VEGF and the combination of these two in NPC patients. The role of LMP-1 protein in the induction of VEGF is identified by analyzing the association between these two proteins.
METHODS: A cross-sectional design study is conducted at Adam Malik General Hospital. Formalin-fixed, paraffin-embedded sections from the NPC tissue samples are submitted for immunohistochemistry staining. Fisher’s exact test is used to analyze variables relation.
RESULTS: Among 56 samples, there was a significant correlation between LMP-1 protein overexpression with histopathological type and clinical staging, and VEGF overexpression with lymph node enlargement and clinical staging (p < 0.05). There was no significant correlation between LMP-1 protein with VEGF in NPC patients (p > 0.05).
CONCLUSION: Increased expressions of LMP-1 protein, VEGF, and a combination of LMP-1 protein and VEGF are noted in correlation with increasing the clinical stages. In contrast to the previously suggested hypotheses, the correlation between these two proteins is not significant in the present study. It could happen due to the different associations of each protein overexpression toward the clinical parameter. However, these two proteins could be used in evaluating the prognosis and providing a targeted therapy to NPC.
Plum Analytics Artifact Widget Block
Mahdavifar N, Towhidi F, Makhsosi BR, Pakzad R, Moini A, Ahmadi A, et al. Incidence and mortality of nasopharynx cancer and its relationship with human development index in the world in 2012. World J Oncol. 2016;7(5-6):109. https://doi. org/10.14740/wjon980w PMid:28983375
Zeng MS, Zeng YX. Pathogenesis and Etiology of Nasopharyngeal Carcinoma. Nasopharyngeal Cancer. Berlin, Germany: Springer; 2010. p. 9-25.
Wei KR, Zheng RS, Zhang SW, Liang ZH, Ou ZX, Chen WQ. Nasopharyngeal carcinoma incidence and mortality in China in 2010. Chin J Cancer. 2014;33(8):381. PMid:25096544
Chua ML, Wee JT, Hui EP, Chan AT. Nasopharyngeal carcinoma. Lancet. 2016;387(10022):1012-24. https://doi.org/10.1016/ s0140-6736(15)00055-0 PMid:26321262
Huang S, Tsao S, Tsang C. Interplay of viral infection, host cell factors and tumor microenvironment in the pathogenesis of nasopharyngeal carcinoma. Cancers. 2018;10(4):106. https:// doi.org/10.3390/cancers10040106 PMid:29617291
Gourzones C, Busson P, Raab-Traub N. Epstein-barr Virus and the Pathogenesis of Nasopharyngeal Carcinomas. Nasopharyngeal Carcinoma. Berlin, Germany: Springer; 2013. p. 42-60. https://doi.org/10.1007/978-1-4614-5947-7_4
Tulalamba W, Janvilisri T. Nasopharyngeal carcinoma signaling pathway: An update on molecular biomarkers. Int J Cell Biol. 2012;2012:10. https://doi.org/10.1155/2012/594681
Yoshizaki T, Kondo S, Wakisaka N, Murono S, Endo K, Sugimoto H, et al. Pathogenic role of epstein-barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma. Cancer Lett. 2013;337(1):1-7. https://doi. org/10.1016/j.canlet.2013.05.018 PMid:23689138
Li YH, Hu CF, Shao Q, Huang MY, Hou JH, Xie D, et al. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. J Transl Med. 2008;6(1):1. https:// doi.org/10.1186/1479-5876-6-1 PMid:18171482
Kim TJ, Lee YS, Kang JH, Kim YS, Kang CS. Prognostic significance of expression of vegf and cox-2 in nasopharyngeal carcinoma and its association with expression of C-erbB2 and EGFR. J Surg Oncol. 2011;103(1):46-52. https://doi. org/10.1002/jso.21767 PMid:21031415
Yang G, Deng Q, Fan W, Zhang Z, Xu P, Tang S, et al. Cyclooxygenase-2 expression is positively associated with lymph node metastasis in nasopharyngeal carcinoma. PLoS One. 2017;12(3):e0173641. https://doi.org/10.1371/journal. pone.0173641 PMid:28301518
Huang D, Song SJ, Wu ZZ, Wu W, Cui XY, Chen JN, et al. Epstein-barr virus-induced VEGF and GM-CSF drive nasopharyngeal carcinoma metastasis via recruitment and activation of macrophages. Cancer Res. 2017;77(13):3591-604. https://doi.org/10.1158/0008-5472.can-16-2706 PMid:28484077
Stevenson D, Charalambous C, Wilson JB. Epstein-barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGFα concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9. Cancer Res. 2005;65(19):8826-35. https://doi. org/10.1158/0008-5472.can-05-0591
Dawson CW, Laverick L, Morris MA, Tramoutanis G, Young LS. Epstein-barr virus-encoded LMP-1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway. J Virol. 2008;82(7):3654-64. https://doi.org/10.1128/jvi.01888-07 PMid:18199641
Xu Y, Shi Y, Yuan Q, Liu X, Yan B, Chen L, et al. Epstein-barr virus encoded LMP-1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells. J Exp Clin Cancer Res. 2013;32(1):90. https://doi.org/10.1186/1756-9966-32-90 PMid:24499623
Zheng H, Li L, Hu D, Deng X, Cao Y. Role of epstein-barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol. 2007;4(3):185-96. PMid:17601372
You S, Zhang F, Meng F, Li H, Liu Q, Liang Y, et al. EBV-encoded LMP-1 increases nuclear β-catenin accumulation and its transcriptional activity in nasopharyngeal carcinoma. Tumor Biol. 2011;32(4):623-30. https://doi.org/10.1007/ s13277-011-0161-x PMid:21336584
Chew MM, Gan SY, Khoo AS, Tan EL. Interleukins, laminin and epstein-barr virus latent membrane protein 1 (EBV LMP-1) promote metastatic phenotype in nasopharyngeal carcinoma. BMC Cancer. 2010;10(1):574. https://doi. org/10.1186/1471-2407-10-574. PMid:20964870
Wang Z, Luo F, Li L, Yang L, Hu D, Ma X, et al. STAT3 activation induced by epstein-barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling. Eur J Cancer. 2010;46(16):2996-3006. https://doi.org/10.1016/j. ejca.2010.07.008 PMid:20709526
Aga M, Bentz GL, Raffa S, Torrisi MR, Kondo S, Wakisaka N, et al. Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP-1-positive exosomes. Oncogene. 2014;33(37):4613. https://doi.org/10.1038/onc.2014.66 PMid:24662828
Wang A, Zhang W, Jin M, Zhang J, Li S, Tong F, et al. Differential expression of EBV proteins LMP-1 and BHFR1 in EBV associated gastric and nasopharyngeal cancer tissues. Mol Med Rep. 2016;13(5):4151-8. https://doi.org/10.3892/ mmr.2016.5087
Borthakur P, Kataki K, Keppen C, Khamo V, Medhi S, Deka M. Expression of epstein barr virus encoded EBNA1 and LMP-1 oncoproteins in nasopharyngeal carcinomas from Northeast India. Asian Pac J Cancer Prev. 2016;17(7):3411-6. PMid:27509984
Rosales-Pérez S, Cano-Valdez AM, Flores-Balcázar CH, Guedea-Edo F, Lino-Silva LS, Lozano-Borbalas A, et al. Expression of epstein-barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): A clinicopathological study. Arch Med Res. 2014;45(3):229-36. https://doi.org/10.1016/j. arcmed.2014.02.002 PMid:24606815
Tabyaoui I, Serhier Z, Sahraoui S, Sayd S, Cadi R, Bennani O, et al. Immunohistochemical expression of latent membrane protein 1 (LMP-1) and p53 in nasopharyngeal carcinoma: Moroccan experience. Afr Health Sci. 2013;13(3):710-7. https:// doi.org/10.4314/ahs.v13i3.27 PMid:24250311
Kurnianda J, Hardianti MS, Harijadi TH, Purwanto I, Haryana SM, Tjokronagoro M. Elevation of vascular endothelial growth factor in Indonesian advanced stage nasopharyngeal carcinoma. Kobe J Med Sci. 2009;55(2):E36-44. PMid:20847590
Krishna SM, James S, Balaram P. Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status. Virus Res. 2006;115(1):85-90. https:// doi.org/10.1016/j.virusres.2005.07.010 PMid:16139912
Pan J, Tang T, Xu L, Lu JJ, Lin S, Qiu S, et al. Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma. Head Neck. 2013;35(9):1238-47. https://doi.org/10.1002/hed.23116 PMid:22972415
Xinhua X, Guoqing H, Song L, Feng X, Daojun L, Delan D, et al. Expression of cyclooxygenase-2 in nasopharyngeal carcinoma and its relation to angiogenesis and prognosis. Chin German J Clin Oncol. 2006;5(2):104-7.
Sha D, He YJ. Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma. Ai Zheng. 2006;25(2):229-34. PMid:16480593
Segawa Y, Oda Y, Yamamoto H, Shiratsuchi H, Hirakawa N, Komune S, et al. Close correlation between CXCR4 and VEGF expression and their prognostic implications in nasopharyngeal carcinoma. Oncol Rep. 2009;21(5):1197-202. https://doi. org/10.3892/or_00000341 PMid:19360294
Paydas S, Ergin M, Erdogan S, Seydaoglu G. Prognostic significance of EBV-LMP-1 and VEGF-A expressions in non-hodgkin’s lymphomas. Leuk Res. 2008;32(9):1424-30. https:// doi.org/10.1016/j.leukres.2008.01.008
Xu S, Bai J, Zhuan Z, Li B, Zhang Z, Wu X, et al. EBV LMP-1 is involved in vasculogenic mimicry formation via VEGFA/ VEGFR1 signaling in nasopharyngeal carcinoma. Oncol Rep. 2018;40(1):377-84. https://doi.org/10.3892/or.2018.6414 PMid:29749553
Copyright (c) 2020 Jessy Chrestella, Farhat Farhat, Elvita Rahmi Daulay, Sheba Tarigan, Raudah Putri Syari (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All rights reserved.